Project Grant P30GM154630

Award Date 8/1/24
Completion Date 7/31/29
Dollars Obligated $1.1M
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Charleston, SC 29425, USA
Similar Awards
This $480,000 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) will enable the Medical University of South Carolina (MUSC) to acquire a high-performance computing (HPC) cluster with extensive data storage and graphics co-processor (GCP) capabilities. This HPC infrastructure will support the integration of MUSC's expanding institutional data resources, including electronic health records, clinical...
This $567,010 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports the Medical Scientist Training Program (MSTP) at the Medical University of South Carolina (MUSC). The primary goal is to train the next generation of physician-scientists who will integrate basic and clinical sciences to improve human health and treat diseases. Key elements of the program include: Providing a...
This $652,497 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, supports a study on the neurological substrates of proximal upper extremity motor control and recovery after stroke. The primary awardee, The General Hospital Corporation (doing business as Massachusetts General Hospital), will conduct three specific aims: (1)...
This Project Grant award of $492,869 from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) will fund a 5-year study to evaluate the effects of a modified cardiac rehabilitation program, called PC3-BAMS, on improving physical and psychosocial function in community-dwelling stroke survivors with and without post-stroke depression. The Medical University of South Carolina, the prime awardee, will deliver the...
This federal Project Grant award of $1,023,404 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will support research to investigate the role of cerebrovascular O-GlcNAcylation in predisposing diabetics to stroke, worsening post-stroke neurovascular injury, and impairing functional recovery. The research will be conducted by the University of South Carolina, a state-controlled public research university, and will...
This federal Project Grant award of $221,120.00 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to improve neural progenitor (NP) survival and migration for the treatment of neurodegenerative diseases and brain injuries. The project investigates the potential of adult central nervous system (CNS) endothelial cells to express developmental...
This federal Project Grant award of $492,749 from the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders is funding the development of a non-invasive magnetic resonance imaging (MRI) technique to better assess tissue acidosis and predict outcomes in acute ischemic stroke. The key goals are to create a "ratiometric dual contrast (RDUAL) pH-weighted MRI" approach that can more...
This federal Project Grant award, valued at $1,133,250.00 and sponsored by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to identify and mechanistically explain "motor superperformance" through the study of a point mutation in the RIF1 gene. The research aims to understand how this mutation enhances motor function, neurophysiology, and...
The National Science Foundation awarded New York University a $100,000 Project Grant under the Engineering (47.041) federal grant program. The grant will support the development of a robust, reliable biomarker for assessing post-stroke motor recovery. Specifically, NYU will design and validate a noninvasive biomarker quantifying the directional information exchange between brain and muscle regions after a stroke. This will be accomplished through analyzing cortical sources involved in...
This $1,149,995.00 Project Grant award from the National Science Foundation (NSF) Computer and Information Science and Engineering (CISE) Program (CFDA 47.070) supports research at New York University (NYU) School of Medicine to develop innovative methods in artificial intelligence (AI) and motion capture technology to analyze patient movement and improve stroke rehabilitation. The key objectives of the project are to: 1) develop a method to integrate multimodal data into a shared representation...

This federal Project Grant award, valued at $1,132,500.00 and issued by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports research at the Medical University of South Carolina (MUSC) focused on the restoration of neural-based function.

The grant aims to optimize MUSC's existing stroke recovery research programs and infrastructure, and implement strategies to advance the university's research excellence in the restoration of neural-based function beyond the COBRE funding period. Key objectives include streamlining specialty services in the Brain Stimulation and Neuroimaging Cores into a more focused Neural Function Core, coalescing COBRE operations and human capital within a new research facility to foster transdisciplinary collaboration, and leveraging faculty growth and diversity programs to sustain long-term COBRE growth. The award will also support a robust pilot project program to drive novel mechanistic and technological innovations in neuromodulation interventions for restoring neural-based functions across physical, cognitive, and psychiatric domains.

Generated 7/1/25, 4:51 AM